Table 1.

The Relationship Between H2AFZ, H2AFV and HCC Clinical Features

Clinicopathological Parameters		N	H2AFZ Expression	P-value	H2AFV Expression	P-value
Age	≤50	78	50.53 ± 36.35	0.079	22.66 ± 9.49	0.18
	>50	292	43.66 ± 28.88		21.23 ± 8.05
Gender	Female	121	46.60 ± 29.44	0.54	22.89 ± 8.49	0.028*
	Male	250	44.50 ± 31.29		20.86 ± 8.25
Child–Pugh grade	A	217	42.11 ± 26.63	0.37	20.75 ± 7.72	0.39
	B+C	22	36.81 ± 22.01		19.29 ± 6.36
AFP	≤200	201	38.69 ± 23.99	1.6x10−4*	20.19 ± 7.31	0.014*
	>200	77	54.64 ± 32.47		22.78 ± 7.87
Grade	G1	55	34.15 ± 23.56	0.000008*	20.50 ± 8.89	0.032*
	G2	177	41.25 ± 26.57		20.45 ± 7.53
	G3	122	54.02 ± 36.40		23.02 ± 8.95
	G4	12	66.15 ± 26.75		24.00 ± 8.42
Cancer status	Tumor free	234	44.49 ± 32.15	0.91	21.10 ± 8.68	0.21
	With tumor	110	44.88 ± 28.09		22.32 ± 7.69
Pathologic stage	I	171	37.53 ± 23.83	0.000006*	19.92 ± 7.08	0.001*
	II	86	50.33 ± 34.69		22.39 ± 8.29
	III	85	56.88 ± 35.48		24.04 ± 10.24
	IV	5	32.35 ± 9.22		17.48 ± 7.85
T classification	T1	181	37.47 ± 24.05	0.000013*	19.83 ± 7.13	0.001*
	T2	94	50.86 ± 33.76		22.91 ± 8.40
	T3	80	54.69 ± 35.40		23.70 ± 10.03
	T4	13	58.46 ± 33.71		22.22 ± 9.78
N classification	N0	252	45.82 ± 31.59	0.51	21.81 ± 8.73	0.76
	N1	4	59.28 ± 24.51		23.16 ± 10.80
M classification	M0	266	46.17 ± 31.94	0.49	21.77 ± 8.55	0.45
	M1	4	35.06 ± 8.02		18.48 ± 8.69
Vascular tumor cell	None	206	40.03 ± 25.60	0.10	21.02 ± 8.27	0.81
	Micro	93	45.66 ± 29.60		21.64 ± 8.25
	Macro	16	51.21 ± 30.92		20.66 ± 7.42
Vital status	Alive	206	40.03 ± 25.60	0.095	21.02 ± 8.27	0.55
	Dead	93	45.66 ± 29.60		21.64 ± 8.25

Notes: *P<0.05. AFP: alpha fetoprotein.